SILVERMAN LOU — SEC Form 4 filings
SEC reporting owner CIK 1249935. 10 Form 4 filings on record with FilingPulse; latest filed 2026-07-06.
Transaction summary — filings shown
Covers all 10 filings on record, filed 2024-07-03 to 2026-07-06. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): none reported.
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 12.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| STAAR SURGICAL CO (STAA) | Director | 3 | — | — | 5 |
| Insight Molecular Diagnostics Inc. (IMDX) | Director | 4 | — | — | 4 |
| Veradigm Inc. (MDRX) | Director | 3 | — | — | 3 |
Form 4 filings — SILVERMAN LOU
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-07-06 | 4 | Insight Molecular Diagnostics Inc. (IMDX) | Tax withholding (F): 7,700 @ $5.69 | EDGAR |
| 2026-06-22 | 4 | STAAR SURGICAL CO (STAA) | Option exercise (M): 10,683 @ $0 · Option exercise (M): 10,683 (derivative) @ $0 · Grant/award (A): 6,182 (derivative) @ $0 | EDGAR |
| 2026-06-15 | 4 | Insight Molecular Diagnostics Inc. (IMDX) | Grant/award (A): 26,943 @ $0 | EDGAR |
| 2026-06-03 | 4 | Veradigm Inc. (MDRX) | Grant/award (A): 42,507 @ $0 | EDGAR |
| 2025-07-03 | 4 | Insight Molecular Diagnostics Inc. (IMDX) | Grant/award (A): 35,000 @ $0 | EDGAR |
| 2025-06-20 | 4 | STAAR SURGICAL CO (STAA) | Grant/award (A): 10,683 (derivative) @ $0 | EDGAR |
| 2025-06-03 | 4 | Veradigm Inc. (MDRX) | Grant/award (A): 46,512 @ $4.30 | EDGAR |
| 2025-05-13 | 4 | STAAR SURGICAL CO (STAA) | Grant/award (A): 2,440 (derivative) @ $0 | EDGAR |
| 2025-03-26 | 4 | Veradigm Inc. (MDRX) | Grant/award (A): 10,112 @ $0 | EDGAR |
| 2024-07-03 | 4 | Oncocyte Corp (OCX) | Grant/award (A): 30,000 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1249935 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →